<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03220000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P09917</UniProt_ID>
  <Seq_Length>674</Seq_Length>
  <Molecule_Weight>77983</Molecule_Weight>
  <KEGG_ID>hsa:240</KEGG_ID>
  <Orthology_ID>K00461</Orthology_ID>
  <EBI_ID>EBI-79934</EBI_ID>
  <Function_Summary>Catalyzes the first step in leukotriene biosynthesis, and thereby plays a role in inflammatory processes.</Function_Summary>
  <Catalytic_Mechanism>Arachidonate + O(2) = leukotriene A(4) + H(2)O.</Catalytic_Mechanism>
  <Pfam_ID>PF00305:Lipoxygenase@@PF01477:PLAT</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>7</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>5-LO</Alias>
      <Alias>5-lipoxygenase</Alias>
      <Alias>Leukotriene A4 synthase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with iron (Fe) ions.</Detail>
      <Keyword>Iron ion binding</Keyword>
      <Ontology_ID>GO:0005506</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: arachidonate + O2 = (6E,8Z,11Z,14Z)-(5S)-5-hydroperoxycosa-6,8,11,14-tetraenoate.</Detail>
      <Keyword>Arachidonate 5-lipoxygenase activity</Keyword>
      <Ontology_ID>GO:0004051</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: linoleate + O2 = (9Z,11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate.</Detail>
      <Keyword>Lipoxygenase activity</Keyword>
      <Ontology_ID>GO:0016165</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from one donor, and two oxygen atoms is incorporated into a donor.</Detail>
      <Keyword>Oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</Keyword>
      <Ontology_ID>GO:0016702</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>254</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.</Detail>
      <Keyword>Leukotriene biosynthetic process</Keyword>
      <Ontology_ID>GO:0019370</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving prostanoids, any compound based on or derived from the prostanoate structure.</Detail>
      <Keyword>Prostanoid metabolic process</Keyword>
      <Ontology_ID>GO:0006692</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>524</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>272</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGCNPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYYYLSPDRIPNSVAI</Protein_Seq>
    <DNA_Seq>GCTAGATGCGGACACCTGGACCGCCGCGCCGAGGCTCCCGGCGCTCGCTGCTCCCGCGGCCCGCGCCATGCCCTCCTACACGGTCACCGTGGCCACTGGCAGCCAGTGGTTCGCCGGCACTGACGACTACATCTACCTCAGCCTCGTGGGCTCGGCGGGCTGCAGCGAGAAGCACCTGCTGGACAAGCCCTTCTACAACGACTTCGAGCGTGGCGCGGTGGATTCATACGACGTGACTGTGGACGAGGAACTGGGCGAGATCCAGCTGGTCAGAATCGAGAAGCGCAAGTACTGGCTGAATGACGACTGGTACCTGAAGTACATCACGCTGAAGACGCCCCACGGGGACTACATCGAGTTCCCCTGCTACCGCTGGATCACCGGCGATGTCGAGGTTGTCCTGAGGGATGGACGCGCAAAGTTGGCCCGAGATGACCAAATTCACATTCTCAAGCAACACCGACGTAAAGAACTGGAAACACGGCAAAAACAATATCGATGGATGGAGTGGAACCCTGGCTTCCCCTTGAGCATCGATGCCAAATGCCACAAGGATTTACCCCGTGATATCCAGTTTGATAGTGAAAAAGGAGTGGACTTTGTTCTGAATTACTCCAAAGCGATGGAGAACCTGTTCATCAACCGCTTCATGCACATGTTCCAGTCTTCTTGGAATGACTTCGCCGACTTTGAGAAAATCTTTGTCAAGATCAGCAACACTATTTCTGAGCGGGTCATGAATCACTGGCAGGAAGACCTGATGTTTGGCTACCAGTTCCTGAATGGCTGCAACCCTGTGTTGATCCGGCGCTGCACAGAGCTGCCCGAGAAGCTCCCCGTGACCACGGAGATGGTAGAGTGCAGCCTGGAGCGGCAGCTCAGCTTGGAGCAGGAGGTCCAGCAAGGGAACATTTTCATCGTGGACTTTGAGCTGCTGGATGGCATCGATGCCAACAAAACAGACCCCTGCACACTCCAGTTCCTGGCCGCTCCCATCTGCTTGCTGTATAAGAACCTGGCCAACAAGATTGTCCCCATTGCCATCCAGCTCAACCAAATCCCGGGAGATGAGAACCCTATTTTCCTCCCTTCGGATGCAAAATACGACTGGCTTTTGGCCAAAATCTGGGTGCGTTCCAGTGACTTCCACGTCCACCAGACCATCACCCACCTTCTGCGAACACATCTGGTGTCTGAGGTTTTTGGCATTGCAATGTACCGCCAGCTGCCTGCTGTGCACCCCATTTTCAAGCTGCTGGTGGCACACGTGAGATTCACCATTGCAATCAACACCAAGGCCCGTGAGCAGCTCATCTGCGAGTGTGGCCTCTTTGACAAGGCCAACGCCACAGGGGGCGGTGGGCACGTGCAGATGGTGCAGAGGGCCATGAAGGACCTGACCTATGCCTCCCTGTGCTTTCCCGAGGCCATCAAGGCCCGGGGCATGGAGAGCAAAGAAGACATCCCCTACTACTTCTACCGGGACGACGGGCTCCTGGTGTGGGAAGCCATCAGGACGTTCACGGCCGAGGTGGTAGACATCTACTACGAGGGCGACCAGGTGGTGGAGGAGGACCCGGAGCTGCAGGACTTCGTGAACGATGTCTACGTGTACGGCATGCGGGGCCGCAAGTCCTCAGGCTTCCCCAAGTCGGTCAAGAGCCGGGAGCAGCTGTCGGAGTACCTGACCGTGGTGATCTTCACCGCCTCCGCCCAGCACGCCGCGGTCAACTTCGGCCAGTACGACTGGTGCTCCTGGATCCCCAATGCGCCCCCAACCATGCGAGCCCCGCCACCGACTGCCAAGGGCGTGGTGACCATTGAGCAGATCGTGGACACGCTGCCCGACCGCGGCCGCTCCTGCTGGCATCTGGGTGCAGTGTGGGCGCTGAGCCAGTTCCAGGAAAACGAGCTGTTCCTGGGCATGTACCCAGAAGAGCATTTTATCGAGAAGCCTGTGAAGGAAGCCATGGCCCGATTCCGCAAGAACCTCGAGGCCATTGTCAGCGTGATTGCTGAGCGCAACAAGAAGAAGCAGCTGCCATATTACTACTTGTCCCCAGACCGGATTCCGAACAGTGTGGCCATCTGAGCACACTGCCAGTCTCACTGTGGGAAGGCCAGCTGCCCCAGCCAGATGGACTCCAGCCTGCCTGGCAGGCTGTCTGGCCAGGCCTCTTGGCAGTCACATCTCTTCCTCCGAGGCCAGTACCTTTCCATTTATTCTTTGATCTTCAGGGAACTGCATAGATTGATCAAAGTGTAAACACCATAGGGACCCATTCTACACAGAGCAGGACTGCACAGCGTCCTGTCCACACCCAGCTCAGCATTTCCACACCAAGCAGC</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>ALOX5</Gene_Name>
    <Gene_Alias>LOG5</Gene_Alias>
    <Gene_ID>240</Gene_ID>
    <Genbank_ACCN>NM_000698</Genbank_ACCN>
    <Protein_ACCN>NP_000689</Protein_ACCN>
    <HGNC_ID>435</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/240</Gene_URL>
    <UCSC_ID>uc001jce.3</UCSC_ID>
    <EMBL_ID>ENSG00000012779</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q14019</Uniprot_ID>
      <Gene_Name>COTL1</Gene_Name>
      <EBI_ID>EBI-79926</EBI_ID>
      <PPI_EBI_URL>EBI-79934,EBI-79926</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Asthma, Diminished Response to Antileukotriene Treatment in</Disease_Name>
      <Disease_Detail>Asthma</Disease_Detail>
      <Disease_DB>AST017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/asthma_diminished_response_to_antileukotriene_treatment_in?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculous Meningitis</Disease_Name>
      <Disease_Detail>Tuberculous Meningitis</Disease_Detail>
      <Disease_DB>TBR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculous_meningitis?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Pulmonary Hypertension</Disease_Name>
      <Disease_Detail>Primary Pulmonary Hypertension</Disease_Detail>
      <Disease_DB>PRM021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_pulmonary_hypertension?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glutathione Synthetase Deficiency</Disease_Name>
      <Disease_Detail>Glutathione Synthetase Deficiency</Disease_Detail>
      <Disease_DB>GLT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glutathione_synthetase_deficiency?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Asthma</Disease_Name>
      <Disease_Detail>Asthma</Disease_Detail>
      <Disease_DB>AST005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/asthma?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteoporosis</Disease_Name>
      <Disease_Detail>Osteoporosis</Disease_Detail>
      <Disease_DB>OST002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteoporosis?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Paranasal Sinus Disease</Disease_Name>
      <Disease_Detail>Paranasal Sinus Disease</Disease_Detail>
      <Disease_DB>PRN021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/paranasal_sinus_disease?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Urticaria</Disease_Name>
      <Disease_Detail>Urticaria</Disease_Detail>
      <Disease_DB>URT039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/urticaria?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningioma</Disease_Name>
      <Disease_Detail>Meningioma</Disease_Detail>
      <Disease_DB>MNN012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningioma?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Arthus Reaction</Disease_Name>
      <Disease_Detail>Arthus Reaction</Disease_Detail>
      <Disease_DB>ART006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/arthus_reaction?search=ALOX5#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atherosclerosis</Disease_Name>
      <Disease_Detail>Atherosclerosis</Disease_Detail>
      <Disease_DB>ATH003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atherosclerosis?search=ALOX5#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>S663D Stable-5-LOX</PDB_Title>
      <PDB_ID>3V98</PDB_ID>
      <Resolution>2.07</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V98</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663.</PubMed_Title>
      <Author>Gilbert, N.C., et al.</Author>
      <Journal>Faseb J.(2012)26:3222-3229</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22516296?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>S663A Stable-5-LOX</PDB_Title>
      <PDB_ID>3V92</PDB_ID>
      <Resolution>2.74</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V92</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663.</PubMed_Title>
      <Author>Gilbert, N.C., et al.</Author>
      <Journal>Faseb J.(2012)26:3222-3229</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22516296?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Stable-5-Lipoxygenase</PDB_Title>
      <PDB_ID>3O8Y</PDB_ID>
      <Resolution>2.39</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3O8Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structure of human 5-lipoxygenase.</PubMed_Title>
      <Author>Gilbert, N.C., et al.</Author>
      <Journal>Science(2011)331:217-219</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21233389?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>S663D Stable-5-LOX in complex with Arachidonic Acid</PDB_Title>
      <PDB_ID>3V99</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3V99</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic phosphorylation at Serine-663.</PubMed_Title>
      <Author>Gilbert, N.C., et al.</Author>
      <Journal>Faseb J.(2012)26:3222-3229</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22516296?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00590</Pathway_ID>
      <Pathway_Title>Arachidonic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00590</Pathway_ID>
      <Pathway_Title>Arachidonic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05145</Pathway_ID>
      <Pathway_Title>Toxoplasmosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04913</Pathway_ID>
      <Pathway_Title>Ovarian steroidogenesis</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04726</Pathway_ID>
      <Pathway_Title>Serotonergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.13.11.34</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/13/11/34.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD03220001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03220007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>